Mizolastine
![]() |
- ₹8300 - ₹15000
- Product name: Mizolastine
- CAS: 108612-45-9
- MF: C24H25FN6O
- MW: 432.49
- EINECS:1308068-626-2
- MDL Number:MFCD23140913
- Synonyms:4(1h)-pyrimidinone,2-((1-(1-((4-fluorophenyl)methyl)-1h-benzimidazol-2-yl)-4-p ;iperidinyl)methylamino)- ;2-[[1-[1-[(4-fluorophenyl)methyl]benzoimidazol-2-yl]-4-piperidyl]-methyl-amino]-3h-pyrimidin-4-one;MIZOLASTINE;2-[[1-[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(1H)-pyrimidinone;Mizolastine HCl;2-[[1-[1-(4-fluorobenzyl)benzimidazol-2-yl]-4-piperidyl]-methyl-amino]-1H-pyrimidin-6-one;2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methyl-amino]-1H-pyrimidin-6-one
2 prices
Selected condition:
Brand
- TCI Chemicals (India)
Package
- 1G
- 5G
- ManufacturerTCI Chemicals (India)
- Product numberM2756
- Product descriptionMizolastine
- Packaging1G
- Price₹8300
- Updated2022-05-26
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberM2756
- Product descriptionMizolastine
- Packaging5G
- Price₹15000
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
TCI Chemicals (India) | M2756 | Mizolastine | 1G | ₹8300 | 2022-05-26 | Buy |
TCI Chemicals (India) | M2756 | Mizolastine | 5G | ₹15000 | 2022-05-26 | Buy |
Properties
Melting point :217°
Density :1.34±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Chloroform (Slightly, Heated), DMSO, Methanol (Slightly, Heated)
form :Solid
pka :9.73±0.40(Predicted)
color :White
Merck :14,6221
Density :1.34±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Chloroform (Slightly, Heated), DMSO, Methanol (Slightly, Heated)
form :Solid
pka :9.73±0.40(Predicted)
color :White
Merck :14,6221
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Mizolastine was marketed in Germany and Switzerland as Mizollen for the symptomatic relief of seasonal and perennial allergic rhinoconjunctivitis and urticaria. Mizolastine is a new long-acting, orally active antihistaminic agent with a rapid onset of action ; the two most recent H1 antagonists launched were fexofenadine, metabolite of terfenadine (Sepracor, 1996) and Olopatadine (Kyowa Hakko, 1997). Mizolastine can be prepared in 2 steps from 2-chloro 1- (4-fluorobenzyl)benzimidazole by successive condensations of appropriate amine and thioether. Mizolastine selectively blocks the peripheral H1 receptors (but not the serotonergic, noradrenergic, muscarinic receptors) with a minimal occupancy of brain receptors, and therefore does not elicit any sedative effects. Moreover, Mizolastine does not produce cardiac rhythm disorders which have been associated with certain non-sedating antihistamines in humans.Related product price
- Methimazole
₹1926.85-15490.58 - Methyl acetate
₹567-42314.93 - Carmustine
₹8356.9-32345.1